There are numerous reports of significantly higher rates of peritumoral edema after SRS for parasagittal meningiomas...I'm sure that's where their caution is coming from, and rightfully so. Reason for that observation isn't clear...for meningiomas it's really a "basal" vs "non-basal" observation. Assumption is that more interface with the pial surface, with vascular/venous occlusion also a potential factor near the sinus. Leland Rogers I believe has summarized this in some meningioma reviews.
How that should impact dose, and whether pertinent for mets...unclear to my knowledge. If it's small met without contact of the dura I wouldn't worry too much just about the sagittal sinus getting dose...but if it's 3.5 cm superficial location you might wanna fractionate or modify dose accordingly.